A Phase II Trial of Pemetrexed (Alimta) in the Treatment of Recurrent or Persistent Low Risk Gestational Trophoblastic Tumor.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Pemetrexed (Primary)
- Indications Trophoblastic tumour
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 23 May 2007 Status changed from in progress to completed.
- 12 May 2007 Status changed from recruiting to in progress.
- 24 Aug 2006 Status change